Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Abdera Therapeutics Inc.

Abdera Therapeutics Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
From Abdera Therapeutics Inc.
Via Business Wire
Abdera Therapeutics to Present Key Updates on its Radiopharmaceutical Development Pipeline at the 2025 American Association for Cancer Research (AACR) Annual Meeting
From Abdera Therapeutics Inc.
Via Business Wire
Abdera Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Abdera Therapeutics Inc.
Via Business Wire
Abdera Therapeutics Announces FDA Fast Track Designation for ABD-147, a Next-Generation Precision Radiopharmaceutical Therapy, for the Treatment of Patients with Extensive-stage Small Cell Lung Cancer
From Abdera Therapeutics Inc.
Via Business Wire
Abdera Therapeutics Announces FDA Clearance of IND Application for ABD-147
From Abdera Therapeutics Inc.
Via Business Wire
Abdera Therapeutics Expands Management Team and Board of Directors
From Abdera Therapeutics Inc.
Via Business Wire
Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer
From Abdera Therapeutics Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.